Development of an electrochemical-based aspartate aminotransferase nanoparticle ir-c biosensor for screening of liver diseases

15Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.

Abstract

Aspartate aminotransaminase (AST) is a hepatocelluar enzyme released into the bloodstream when hepatic cells are damaged, resulting in elevated blood levels of AST. A single use, disposable biosensor prototype, composed of catalytic iridium nano-particles dispersed on carbon paste, was developed to detect enzymatically-produced H2O2 in AST-mediated reactions. This biosensor is capable of measuring AST levels in a phosphate buffer and undiluted human serum over the concentration range of 0 to 0.89 μg/mL AST concentration (corresponding to 0-250 UL-1 specific activity). The biosensor operates at relatively low oxidation potential (+0.3 volt (V) versus the printed Ag/AgCl), minimizing any potential chemical interference in human serum. The measurements of AST in human serum using the biosensor compared well with those measured by standard hospital spectrophotometric assays. This Ir-C biosensor may be useful for AST measurements in the clinical environment. © 2012 by the authors; licensee MDPI, Basel, Switzerland.

Cite

CITATION STYLE

APA

Hsueh Alan, C. J., Wang, J. H., Dai, L., & Liu, C. C. (2012). Development of an electrochemical-based aspartate aminotransferase nanoparticle ir-c biosensor for screening of liver diseases. Biosensors, 2(2), 234–244. https://doi.org/10.3390/bios2020234

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free